Published on
April 20, 2026
- 17:00 GMT
Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes ...
New York, USA, April 20, 2026 (GLOBE NEWSWIRE) -- Pheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | …
Distribution channels:
Media, Advertising & PR
...
